Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Monday morning. The firm issued a hold rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Price Performance

Milestone Scientific stock opened at $1.12 on Monday. Milestone Scientific has a 1-year low of $0.54 and a 1-year high of $1.27. The firm has a market capitalization of $87.34 million, a P/E ratio of -16.02 and a beta of 1.10. The company’s 50-day moving average is $0.87 and its 200 day moving average is $0.90.

Insiders Place Their Bets

In other news, Director Leonard Osser sold 107,984 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 24.75% of the company’s stock.

Hedge Funds Weigh In On Milestone Scientific

A number of hedge funds and other institutional investors have recently modified their holdings of MLSS. Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific in the third quarter valued at approximately $48,000. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the third quarter worth $91,000. Carnegie Investment Counsel raised its holdings in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after buying an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the last quarter. 5.79% of the stock is currently owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.